91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Whole Transcriptomics Sequencing Market Insights, Forecast to 2030

Global Whole Transcriptomics Sequencing Market Insights, Forecast to 2030

Publication ID: 
PB512240685
Publication Date: 
December 17, 2024
Pages: 
86
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 4,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics.
Market Analysis and Insights: Global Whole Transcriptomics Sequencing Market
The global Whole Transcriptomics Sequencing market is projected to grow from US$ 1974 million in 2024 to US$ 5894.3 million by 2030, at a Compound Annual Growth Rate (CAGR) of 20.0% during the forecast period.
A significant driver in the Whole Transcriptomics Sequencing market is the growing demand for comprehensive insights into gene expression and regulation. Whole transcriptomics sequencing offers researchers the ability to analyze the entire transcriptome, providing valuable information on gene expression, alternative splicing, and non-coding RNAs. However, a notable challenge in this market is the need for data analysis and interpretation expertise. Ensuring that researchers can effectively analyze and derive meaningful insights from the vast amount of transcriptomic data generated poses a significant challenge. Bioinformatics tools and computational resources must be continually developed and improved to simplify data analysis and interpretation, allowing researchers to unlock the full potential of whole transcriptomics sequencing in advancing our understanding of gene function and regulation.
Report Covers:
This report presents an overview of global market for Whole Transcriptomics Sequencing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Whole Transcriptomics Sequencing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Whole Transcriptomics Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Whole Transcriptomics Sequencing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Whole Transcriptomics Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Whole Transcriptomics Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Whole Transcriptomics Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Whole Transcriptomics Sequencing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Transcriptomics Sequencing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Whole Transcriptomics Sequencing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Whole Transcriptomics Sequencing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Whole Transcriptomics Sequencing Market Perspective (2019-2030)
2.2 Global Whole Transcriptomics Sequencing Growth Trends by Region
2.2.1 Whole Transcriptomics Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Whole Transcriptomics Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Whole Transcriptomics Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Whole Transcriptomics Sequencing Market Dynamics
2.3.1 Whole Transcriptomics Sequencing Industry Trends
2.3.2 Whole Transcriptomics Sequencing Market Drivers
2.3.3 Whole Transcriptomics Sequencing Market Challenges
2.3.4 Whole Transcriptomics Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Whole Transcriptomics Sequencing by Players
3.1.1 Global Whole Transcriptomics Sequencing Revenue by Players (2019-2024)
3.1.2 Global Whole Transcriptomics Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Whole Transcriptomics Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Whole Transcriptomics Sequencing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Whole Transcriptomics Sequencing Market Concentration Ratio
3.4.1 Global Whole Transcriptomics Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Whole Transcriptomics Sequencing Revenue in 2023
3.5 Global Key Players of Whole Transcriptomics Sequencing Head office and Area Served
3.6 Global Key Players of Whole Transcriptomics Sequencing, Product and Application
3.7 Global Key Players of Whole Transcriptomics Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Whole Transcriptomics Sequencing Breakdown Data by Type
4.1 Global Whole Transcriptomics Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Whole Transcriptomics Sequencing Forecasted Market Size by Type (2025-2030)
5 Whole Transcriptomics Sequencing Breakdown Data by Application
5.1 Global Whole Transcriptomics Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Whole Transcriptomics Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Whole Transcriptomics Sequencing Market Size (2019-2030)
6.2 North America Whole Transcriptomics Sequencing Market Size by Type
6.2.1 North America Whole Transcriptomics Sequencing Market Size by Type (2019-2024)
6.2.2 North America Whole Transcriptomics Sequencing Market Size by Type (2025-2030)
6.2.3 North America Whole Transcriptomics Sequencing Market Share by Type (2019-2030)
6.3 North America Whole Transcriptomics Sequencing Market Size by Application
6.3.1 North America Whole Transcriptomics Sequencing Market Size by Application (2019-2024)
6.3.2 North America Whole Transcriptomics Sequencing Market Size by Application (2025-2030)
6.3.3 North America Whole Transcriptomics Sequencing Market Share by Application (2019-2030)
6.4 North America Whole Transcriptomics Sequencing Market Size by Country
6.4.1 North America Whole Transcriptomics Sequencing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Whole Transcriptomics Sequencing Market Size by Country (2019-2024)
6.4.3 North America Whole Transcriptomics Sequencing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Whole Transcriptomics Sequencing Market Size (2019-2030)
7.2 Europe Whole Transcriptomics Sequencing Market Size by Type
7.2.1 Europe Whole Transcriptomics Sequencing Market Size by Type (2019-2024)
7.2.2 Europe Whole Transcriptomics Sequencing Market Size by Type (2025-2030)
7.2.3 Europe Whole Transcriptomics Sequencing Market Share by Type (2019-2030)
7.3 Europe Whole Transcriptomics Sequencing Market Size by Application
7.3.1 Europe Whole Transcriptomics Sequencing Market Size by Application (2019-2024)
7.3.2 Europe Whole Transcriptomics Sequencing Market Size by Application (2025-2030)
7.3.3 Europe Whole Transcriptomics Sequencing Market Share by Application (2019-2030)
7.4 Europe Whole Transcriptomics Sequencing Market Size by Country
7.4.1 Europe Whole Transcriptomics Sequencing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Whole Transcriptomics Sequencing Market Size by Country (2019-2024)
7.4.3 Europe Whole Transcriptomics Sequencing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Whole Transcriptomics Sequencing Market Size (2019-2030)
8.2 China Whole Transcriptomics Sequencing Market Size by Type
8.2.1 China Whole Transcriptomics Sequencing Market Size by Type (2019-2024)
8.2.2 China Whole Transcriptomics Sequencing Market Size by Type (2025-2030)
8.2.3 China Whole Transcriptomics Sequencing Market Share by Type (2019-2030)
8.3 China Whole Transcriptomics Sequencing Market Size by Application
8.3.1 China Whole Transcriptomics Sequencing Market Size by Application (2019-2024)
8.3.2 China Whole Transcriptomics Sequencing Market Size by Application (2025-2030)
8.3.3 China Whole Transcriptomics Sequencing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Whole Transcriptomics Sequencing Market Size (2019-2030)
9.2 Asia Whole Transcriptomics Sequencing Market Size by Type
9.2.1 Asia Whole Transcriptomics Sequencing Market Size by Type (2019-2024)
9.2.2 Asia Whole Transcriptomics Sequencing Market Size by Type (2025-2030)
9.2.3 Asia Whole Transcriptomics Sequencing Market Share by Type (2019-2030)
9.3 Asia Whole Transcriptomics Sequencing Market Size by Application
9.3.1 Asia Whole Transcriptomics Sequencing Market Size by Application (2019-2024)
9.3.2 Asia Whole Transcriptomics Sequencing Market Size by Application (2025-2030)
9.3.3 Asia Whole Transcriptomics Sequencing Market Share by Application (2019-2030)
9.4 Asia Whole Transcriptomics Sequencing Market Size by Region
9.4.1 Asia Whole Transcriptomics Sequencing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Whole Transcriptomics Sequencing Market Size by Region (2019-2024)
9.4.3 Asia Whole Transcriptomics Sequencing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Whole Transcriptomics Sequencing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Whole Transcriptomics Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Whole Transcriptomics Sequencing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Whole Transcriptomics Sequencing Introduction
11.2.4 Illumina Revenue in Whole Transcriptomics Sequencing Business (2019-2024)
11.2.5 Illumina Recent Developments
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Whole Transcriptomics Sequencing Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Whole Transcriptomics Sequencing Business (2019-2024)
11.3.5 QIAGEN (Exiqon) Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Whole Transcriptomics Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Whole Transcriptomics Sequencing Business (2019-2024)
11.4.5 Agilent Technologies Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Whole Transcriptomics Sequencing Introduction
11.5.4 Roche Revenue in Whole Transcriptomics Sequencing Business (2019-2024)
11.5.5 Roche Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Whole Transcriptomics Sequencing Introduction
11.6.4 GE Healthcare Revenue in Whole Transcriptomics Sequencing Business (2019-2024)
11.6.5 GE Healthcare Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Whole Transcriptomics Sequencing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Whole Transcriptomics Sequencing Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 Fluidigm
11.8.1 Fluidigm Company Details
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Whole Transcriptomics Sequencing Introduction
11.8.4 Fluidigm Revenue in Whole Transcriptomics Sequencing Business (2019-2024)
11.8.5 Fluidigm Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned: 

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-whole-transcriptomics-sequencing-market-insights-forecast-2030

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare